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Abstract
Background—Better understanding about gastric cancer incidence patterns among Hispanics by 
birthplace, socioeconomic status (SES), and acculturation can improve preventive strategies and 
disease models.
Methods—Incidence rates, rate ratios, and estimated annual percent change (EAPC) in rates of 
anatomic and histologic subtype-specific gastric cancer were calculated by age, sex, and nativity 
among Hispanics using California Cancer Registry data from 1988 through 2004. Incidence rates 
in 1998 to 2002 were compared by neighborhood SES and Hispanic enclave status according to 
2000 US Census data.
Results—Incidence rates of diffuse gastric cancer increased from 1988 through 2004 among 
foreign-born Hispanic men (EAPC: 3.5%, 95% CI: 1.5%–5.5%) and U.S.-born Hispanic women 
(EAPC: 3.0%, 95% CI: 0.7%–5.3%). During the same time period, incidence rates of intestinal 
gastric cancer declined significantly and both cardia and noncardia gastric cancer were steady or 
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declined among foreign-born and U.S.-born Hispanic men and women. Noncardia and both 
intestinal and diffuse gastric cancer were more common in foreign-born than U.S.-born Hispanic 
men and women, and in those from lower SES, higher enclave neighborhoods. By contrast, among 
younger and middle-aged Hispanic men, cardia tumors were more common in the U.S.-born than 
the foreign-born, and in higher SES, lower enclave neighborhoods.
Conclusions—Varying gastric cancer risk factors among Hispanic subgroups and increasing 
rates of diffuse gastric cancer in foreign-born Hispanic men and U.S.-born Hispanic women merit 
further investigation to identify separate disease etiologies.
Impact—Age, sex, birthplace, SES, and acculturation modify gastric cancer incidence in 
Hispanics and should be considered when examining disease risk and prevention.
Introduction
Gastric cancer is the seventh leading cause of cancer death in U.S. Hispanic males and 
females (1). With incidence rates at least 70% higher in Hispanics than non-Hispanic whites 
(2), gastric cancer is a prominent nationwide ethnic health disparity. Higher rates of gastric 
cancer in Hispanics than in whites, and in Latin America than in the United States (3), are 
likely due primarily to differences in the prevalence of Helicobacter pylori infection—the 
strongest known risk factor for gastric cancer, especially for tumors in the antrum and body 
of the stomach (4). H. pylori transmission via oral–oral and fecal–oral routes is facilitated by 
the generally poorer sanitation and more crowded living conditions found in the countries of 
origin for most Hispanics (4, 5), and these early life environmental conditions contribute to 
the persistent 2- to 3-fold higher prevalence of H. pylori infection in Hispanics than whites 
in the United States (6–8). H. pylori plays a lesser etiologic role in cardia gastric cancer (9), 
however, and may even protect against nonatrophic cardia tumors (10, 11). Instead, obesity 
and gastroesophageal reflux are stronger risk factors for cancer in the cardia (12–14), the 
only anatomic subsite of the stomach for which incidence rates are higher in non-Hispanic 
white males than Hispanic males (15, 16). Other risk factors for both cardia and noncardia 
gastric cancer include smoking (17–19) and, to a lesser extent, diet (20–22). As with 
anatomic subsites of gastric cancer, many risk factors also seem to be shared between the 2 
main histologic subtypes, intestinal and diffuse gastric cancer, although some etiologic 
differences have been described (23).
Recently, using Surveillance, Epidemiology, and End Results (SEER) data from the U.S. 
National Cancer Institute, Anderson and colleagues reported a significant increase in the 
incidence rate of noncardia gastric cancer from 1977 through 2006 among white (combining 
Hispanic and non-Hispanic) men and women aged 25 to 39 years, but significant declines 
among older whites (24). In a sensitivity analysis, Anderson and colleagues noted similar 
age-specific incidence trends among non-Hispanic whites between 1992 and 2006 (24), and 
a follow-up study indicated stable rates over time among Hispanics overall (15).
Better knowledge of gastric cancer incidence patterns in Hispanics can inform management 
of the disease in this fast-growing population and can also provide insight into disease 
causation and offer guidance for potential preventive efforts such as smoking cessation, 
dietary modification, and screening and eradication of H. pylori infection. Although gastric 
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cancer incidence is known to vary by country and ethnicity, little is known about how 
incidence patterns differ by birthplace, acculturation, and socioeconomic status (SES) 
among U.S. Hispanics, nearly 40% of whom are foreign-born and who span the full 
spectrum of acculturation and SES (25). For example, gastric cancer risk may vary by place 
of birth due to differences in early-life exposures, such as H. pylori infection, and other 
differences in lifestyle and environment between immigrants and nonimmigrants (26). 
Residential neighborhood characteristics, including SES and degree of ethnic enclave status 
(as a measure of acculturation) may also affect gastric cancer risk through hygiene practices, 
housing density, access to health care, diet, and cultural and community attitudes about 
obesity and smoking (27–31).
To our knowledge, incidence trends of gastric cancer subtypes by anatomic site and 
histology among Hispanics have not previously been examined by nativity, nor have 
incidence rate patterns been delineated by neighborhood SES and enclave status. Therefore, 
to investigate these compelling public health questions about one of the leading causes of 
cancer death among Hispanics, we examined gastric cancer incidence among Hispanics in 
California, home to the nation’s largest Hispanic population.
Methods
Cancer patient data
We obtained California Cancer Registry data on all California residents diagnosed with 
primary invasive gastric cancer (International Classification of Diseases for Oncology, 3rd 
edition [ICD-O-3] site codes 16.0–16.9, histology codes 8000–8999) from January 1, 1988, 
through December 31, 2004 (32). We included all 9,001 Hispanics/Latinos (hereafter 
referred to as "Hispanics," in accordance with U.S. Office of Management and Budget 
designations) diagnosed with gastric cancer during the study period (5,134 males and 3,867 
females). Classification of Hispanic ethnicity was improved by application of the North 
American Association of Central Cancer Registries Hispanic Identification Algorithm (33). 
We did not further subclassify Hispanics by country of origin due to a high proportion of 
missing data, but approximately 84% of California Hispanics are of Mexican origin (34), 
followed by 9% of Central American origin (35).
Primary gastric tumors were classified according to anatomic location in the cardia (ICD-
O-3 site code 16.0), noncardia (site codes 16.1–16.6), or overlapping/unspecified area (site 
codes 16.8–16.9). Tumors were alternatively classified according to histologic type (36) as 
intestinal (ICD-O-3 histology codes 8010, 8140, 8144, and 8211), diffuse (histology codes 
8490, 8142, and 8145), or other epithelial (all other histology codes excluding 8800–9759 
and 8000–8004), using the same codes as in previous studies for comparability (37, 38). 
Between 1988 and 1992 and 2000 and 2004 in the eligible study population, the percentage 
of gastric tumors with site classified as "unspecified" (20.8%; 19.8%) or histologic type 
classified as "not otherwise specified" (1.2%; 1.4%) did not change appreciably.
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Classification of nativity
Data on nativity were available in the cancer registry for 84.7% of eligible cases. Because 
cancer registry data on birthplace are selectively missing (39, 40), we estimated nativity for 
the minority (15.3%) of patients with unknown birthplace using a statistical imputation 
method that has minimal bias (41). Based on each patient’s social security number (SSN), 
which indicates the state and year of issuance (42, 43), we classified patients who received 
their SSN before age 20 years as U.S.-born and those who received their SSN at or after age 
20 years as foreign-born. The cut point of 20 years was determined by comparisons with 
self-reported nativity from interviews with 1,127 Hispanic cancer patients (39, 40) and 
maximization of the area under the resultant receiver operating characteristic curve. The 
optimal positive predictive value of the age cut point was confirmed by using logistic 
regression models with age at SSN issuance as a continuous predictor of foreign-born status. 
The selected cut point resulted in immigrant status classifications associated with 81% 
sensitivity and 80% specificity for detecting foreign-born status in Hispanics. The less than 
1% of cases with missing or invalid SSNs were assigned a nativity status based on the 
known distribution of nativity within matched strata of race/ethnicity, sex, and age in the 
overall California Cancer Registry patient population.
Classification of neighborhood SES and enclave status
We assigned a neighborhood-level measure of SES based on a previously described index 
that incorporates 2000 U.S. Census data on education, occupation, unemployment, 
household income, poverty, rent, and house values (44). Each of the 99.9% of patients with a 
known residential address at diagnosis was geocoded to a census tract. The remaining cases 
without a street address or whose address could not be precisely geocoded (0.1%) were 
randomly assigned to a census tract within their ZIP code of residence. Based on residential 
census tracts, each patient was assigned to a quintile of neighborhood SES according to the 
statewide distribution of the SES index across all census tracts in California. For the 
analysis, we combined quintiles 1 to 2 (lower SES) and quintiles 3 to 5 (higher SES).
We also classified patients according to neighborhood Hispanic enclave status, based on the 
concept of an ethnic enclave as a geographic unit with higher percentages of foreign-born 
ethnicity-specific residents and non-English language usage. To characterize residence in a 
Hispanic enclave, we applied principal components analysis to 2000 U.S. Census block 
group level data on linguistic isolation, English fluency, Spanish language use, Hispanic 
ethnicity, immigration history, and nativity; these component values were then combined and 
averaged across census tracts as the enclave index (45). Again, each case was assigned to a 
quintile of neighborhood ethnic enclave status based on the distribution of the enclave index 
across all census tracts in California. We combined quintiles 1 to 3 (lower enclave status) 
and quintiles 4 to 5 (higher enclave status) for the analysis.
Analyses of neighborhood SES and ethnic enclave status were limited to the pericensal 
period January 1, 1998, through December 31, 2002, due to data availability, and included 
2,954 cases (1,669 males and 1,285 females) diagnosed with gastric cancer during this 
interval.
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Population data
From the 1990 and 2000 U.S. Census Summary File 3 (SF-3), we obtained population 
counts to estimate incidence rates by sex, race/ethnicity, immigrant status, and 5-year age 
group for California. For intercensal years, we estimated the foreign-born Hispanic 
population size using cohort component interpolation and extrapolation methods, adjusting 
estimates to the populations by age and year provided by the California Department of 
Finance for years 1988 to 1989 and by the U.S. Census for years 1990 to 2004, based on 
data availability. For the analyses of neighborhood SES and ethnic enclave status, we used 
2000 U.S. Census population estimates by race/ethnicity and sex at the census tract level. 
Because census data on nativity are not available at the census tract level, the database 
containing nativity data was separate from the one containing neighborhood SES and ethnic 
enclave status, and these variables could not be cross-classified.
Statistical analysis
We used SEER* Stat software (46) to compute age-adjusted incidence rates (directly 
standardized to the 2000 U.S. standard million population) with 95% CIs. We also calculated 
incidence rate ratios to compare incidence rates between United States and foreign-born 
populations, and between higher and lower neighborhood SES and/or ethnic enclave status. 
Due to incidence rate heterogeneity by age group and sex, we conducted separate analyses 
for men and women aged 25 to 39 years, 40 to 59 years, and 60 years or more. To examine 
incidence rate trends over time, we combined age groups but stratified analyses by year of 
diagnosis (1988–1993, 1994–1999, and 2000–2004) and quantified linear trends by the 
estimated annual percent change (EAPC), calculated by weighted least squares linear 
regression. For a more detailed analysis of incidence rate trends allowing for varying effects 
by chronologic age, calendar year of diagnosis, and year of birth, we used age-period-cohort 
models to compare gastric cancer incidence rate trends by nativity, anatomic subsite, and 
histology, using previously described methods (47, 48), with age and calendar time 
recategorized into 4-year intervals. Age-period-cohort modeling was carried out with 
MATLAB (The Mathworks, Inc.).
Results
Sixty percent of Hispanic males with gastric cancer (N = 3,093) were foreign-born, 
compared with 45% of the general population. Among Hispanic females, 66% of gastric 
cancer cases (N = 2,547) were foreign-born, compared with 43% of the general population.
Time trends
Between 1988 and 1993 and 2000 and 2004, incidence rates of noncardia gastric cancer 
were stable among both foreign-born (EAPC: −0.4%) and U.S.-born Hispanic men (EAPC: 
−1.7%), with a slight but statistically nonsignificant decrease in the latter group (Fig. 1A). 
Incidence rates of cardia gastric cancer, meanwhile, declined significantly in both foreign-
born (EAPC: −3.9%) and U.S.-born Hispanic men (EAPC: −2.7%). When gastric cancer 
was classified according to histologic type instead of anatomic site, however, time trends 
diverged by nativity (Fig. 1B). Whereas intestinal gastric cancer incidence rates declined 
significantly among both foreign-born (EAPC: −3.1%) and U.S.-born Hispanic men (EAPC: 
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−2.3%), diffuse gastric cancer incidence rates increased significantly over time among 
foreign-born Hispanic men (EAPC: 3.5%). By contrast, diffuse gastric cancer incidence 
rates were stable in U.S.-born Hispanic men (EAPC: −1.0%).
Among Hispanic women, incidence rates of noncardia gastric cancer declined significantly 
from 1988 to 1993 through 2000 to 2004 among the foreign-born (EAPC: −1.6%), but not 
the U.S.-born (EAPC: −0.6%; Fig. 2A). In both groups, the incidence rate of cardia gastric 
cancer did not change over time. Again, when time trends in gastric cancer incidence rates 
were examined by histologic type, different patterns were observed by nativity (Fig. 2B). As 
with Hispanic men, intestinal gastric cancer incidence rates decreased significantly over time 
in both foreign-born (EAPC: −3.5%) and U.S.-born Hispanic women (EAPC: −2.8%). 
Diffuse gastric cancer incidence rates, meanwhile, increased significantly over time in U.S.-
born Hispanic women (EAPC: 3.0%), but not foreign-born Hispanic women (EAPC: 1.0%).
Age-period-cohort analysis detected few differences in age-specific trends between U.S.-
born and foreign-born Hispanic men or women, due in part to insufficient sample sizes (data 
not shown). However, there was evidence of a statistically significant positive secular trend 
in the incidence rate of diffuse gastric cancer among Hispanic men ages 25 to 36 years, as 
well as 69 to 76 years, but not other age groups (Pheterogeneity by age = 0.04). By contrast, a 
statistically significant negative secular trend was observed for intestinal gastric cancer in 
nearly all age groups of Hispanic men. Suggestions of similar patterns by histologic type 
were observed among Hispanic women, but differences were not statistically significant.
Patterns by nativity
Incidence rates of noncardia gastric cancer were consistently higher in foreign-born than 
U.S.-born Hispanic men and women (Table 1). The same pattern by nativity was observed 
for cardia gastric cancer among older Hispanic men and women. In the younger and middle 
age groups, however, the opposite pattern was detected among Hispanic men, in whom 
incidence rates of cardia gastric cancer were higher for the U.S.-born than the foreign-born, 
and no differences by nativity were found among Hispanic women in these age groups. 
Incidence rate patterns by nativity for gastric cancer in overlapping or unspecified anatomic 
locations were similar to those for noncardia cancer (data not shown).
When gastric cancer was classified according to histologic type rather than anatomic 
location, the incidence rate ratio by nativity was more consistently elevated for both 
intestinal and diffuse gastric cancer across nearly all age groups of Hispanic men and 
women (Table 2). Incidence rates of other epithelial gastric cancer were also mostly higher 
in foreign-born than U.S.-born Hispanic men and women (data not shown). When limited to 
noncardia anatomic locations (56% of intestinal tumors in men, 62% of intestinal tumors in 
women, 53% of diffuse tumors in men, 57% of diffuse tumors in women), the incidence rate 
ratios comparing foreign-born to U.S.-born remained elevated in all age groups of Hispanic 
men and women (data not shown).
Patterns by neighborhood SES and enclave status
Given that foreign-born Hispanics are more likely to live in lower SES, higher enclave 
neighborhoods (49), incidence patterns by neighborhood SES, and enclave status largely 
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mirrored those by nativity for all age groups combined. In particular, incidence rates of 
noncardia gastric cancer were generally higher among Hispanic men and women living in 
neighborhoods of lower SES and higher enclave status (Table 3). For cardia gastric cancer, 
rates were generally lower in Hispanic men living in lower SES, high-enclave 
neighborhoods, whereas the opposite pattern was observed among Hispanic women, 
although sample sizes were limited in some strata. Again, incidence rate patterns for gastric 
cancer in overlapping or unspecified anatomic locations were largely similar to those for 
noncardia cancer (data not shown).
Histology-specific incidence patterns by neighborhood SES and enclave status also 
paralleled those by nativity, with elevated incidence rates of both intestinal and diffuse 
gastric cancer among Hispanic men and women living in neighborhoods with lower SES and 
higher enclave status (Table 4). Again, some sample sizes were limited for analyses of 
diffuse gastric cancer. Incidence rate ratios were also above 1.0 for other epithelial types of 
gastric cancer and remained elevated when the analysis of intestinal and diffuse types was 
limited to noncardia tumors (data not shown).
Discussion
This is the first study to investigate trends in gastric cancer incidence among Hispanics by 
nativity. Among California Hispanics for the period 1988 through 2004, we observed 
increasing incidence rates of diffuse gastric cancer in foreign-born Hispanic men and U.S.-
born Hispanic women. By contrast, rates of intestinal and both noncardia and cardia gastric 
cancer mostly were steady or declined over time in foreign-born and U.S.-born Hispanic 
men and women. These trends bear some resemblance to the declining rates of intestinal, but 
not diffuse, gastric cancer among whites in the United States and Europe in the 1950s and 
1960s (50–52). By considering differences by nativity, sex, and histologic subtype, our 
results extend the work of Camargo and colleagues, who reported declining incidence rates 
of gastric cancer in the cardia and some noncardia sites among older U.S. Hispanics from 
1999 through 2007. Others previously reported decreasing incidence rates of noncardia and 
intestinal gastric cancers in U.S. whites, blacks, and other races combined (15, 24, 37, 38). 
These decreases have been ascribed primarily to the declining prevalence of H. pylori 
infection due to improved sanitation, economic development, and antibiotic use (53), and 
secondarily to decreasing tobacco use (54) and perhaps some dietary improvements (55).
Contrary to the findings of Anderson and colleagues, who reported a rising trend in 
noncardia gastric cancer among young adult whites (24), the only significant incidence rate 
increases in our study were in certain population subgroups with diffuse gastric cancer, 
although we had limited power to examine time trends in young adult Hispanics. The trends 
that we observed could potentially be explained by a population shift away from CagA-
positive H. pylori strains, which are preferentially associated with intestinal versus diffuse 
gastric cancer (56, 57), or the ascendance of other cofactors such as Epstein-Barr virus, 
which is detected in roughly 8% of gastric tumors and is more strongly associated with 
diffuse than intestinal gastric cancer (58). We speculate that the rising incidence rates of 
diffuse gastric cancer in foreign-born Hispanic men and U.S.-born Hispanic women, but not 
their counterparts, could be due in part to a more rapidly rising prevalence of obesity in the 
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former groups than the latter (47). Increasing incidence rates of diffuse gastric cancer 
through the end of the last decade have been noted previously in white, black, and other-race 
men and women (37, 38), but have not previously been reported by nativity among 
Hispanics.
Besides trends over time, we noted distinct incidence patterns by nativity, with higher rates 
of noncardia, intestinal, and especially diffuse gastric cancer in foreign-born than U.S.-born 
Hispanic men and women. By contrast, for cardia gastric cancer, we found the opposite 
nativity pattern in younger and middle-aged Hispanic men, and no differences by nativity in 
younger and middle-aged Hispanic women. Patterns by neighborhood SES and enclave 
status were comparable, with generally higher rates in lower SES, higher enclave 
neighborhoods for all gastric cancer subtypes except cardia tumors in Hispanic men, who 
had the opposite pattern. Pinheiro and colleagues reported higher incidence rates of overall 
gastric cancer among Mexicans, Puerto Ricans, and Cubans in their countries of origin than 
in Florida in 1999 to 2001 (59), implying higher rates in foreign-born than U.S.-born 
Hispanics, but they were unable to directly examine incidence patterns of gastric cancer 
subtypes by birthplace or residential characteristics.
The most probable explanation for the higher incidence rates of noncardia, intestinal, and, to 
a lesser extent, diffuse gastric cancer in foreign-born than U.S.-born Hispanic men and 
women, and in those living in lower SES, higher enclave neighborhoods, is variation in the 
prevalence of H. pylori infection (7, 8). A serologic study of H. pylori infection among 
Hispanics in the San Francisco Bay Area of California found that the prevalence of infection 
dropped precipitously from 31.4% in foreign-born Hispanics to 9.1% in first-generation 
U.S.-born Hispanics and 3.1% in second-generation U.S.-born Hispanics (27). The same 
study found that after adjustment for immigrant generation, having at least one infected 
parent and a lower level of education were significant predictors of H. pylori infection, 
indicating that some of the differences we detected by neighborhood SES and enclave status 
may have been due to environmental and household factors other than birthplace. These 
findings echoed earlier results from a seroepidemiologic study of H. pylori in Mexico, where 
higher household crowding [a common feature of Hispanic enclaves in the United States 
(60)], lower educational level, and lower SES were independently associated with higher 
risk of infection (61). Besides H. pylori infection, differences in the prevalence of tobacco 
smoking, which is more common in foreign-born than U.S.-born Hispanic men [but not 
women (49)], and infection with Epstein-Barr virus, which usually occurs earlier in foreign-
born Hispanics and those living in lower SES, higher enclave neighborhoods (62, 63), may 
also partially account for some of the observed nativity patterns (17–19).
For gastric cardia cancer, by contrast, the higher incidence rates in U.S.-born than foreign-
born younger and middle-aged Hispanic men, and the higher rates among those living in 
higher SES, lower enclave neighborhoods, may be explained by the greater prevalence of 
obesity in U.S.-born than foreign-born Hispanic men, and in higher-SES than lower SES 
Hispanic men, but not women (49). Intake of fruits and vegetables, a moderate risk factor for 
cardia gastric cancer (20, 22), was also lower in U.S.-born and higher-SES Hispanic men in 
California in 2001 (but not 2005), and lower in Hispanic men overall than in Hispanic 
women (49), and could thus have contributed to the observed incidence rate patterns.
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The impact of undocumented/unlawful immigration on our results was most likely small. 
False reporting of birthplace and SSNs by undocumented immigrants, leading to 
misclassification of some foreign-born Hispanics as U.S.-born, probably affected both 
numerators and denominators of incidence rates, resulting in minimal bias. Erroneous 
imputation of U.S.-born nativity based on false SSNs would have affected only some of the 
15.3% of cases with missing birthplace data in the cancer registry; 84.7% of our nativity 
data was derived from patients’ medical records or death certificates, which we have 
previously shown to be highly accurate for birthplace information (39, 40). Even if the 
proportion of undocumented immigrants among gastric cases was higher than in the overall 
Hispanic population of California [estimated at roughly 15% (64, 65)], they still probably 
represented only a minority of the 15.3% of cases with imputed nativity. Misclassification of 
nativity as U.S.-born also occurred among the small number of documented immigrants who 
received an SSN before age 20 and had missing birthplace information in the cancer registry. 
However, many of those who immigrated in childhood may have more cultural, behavioral, 
and environmental factors in common with U.S.-born Hispanics, with whom they were 
grouped in this analysis, than with foreign-born Hispanics who immigrated as adults.
Besides the potential for moderate misclassification of nativity, our study was also limited 
by the lack of data on individual gastric cancer risk factors, such as H. pylori infection, 
smoking history, obesity, and diet, to help explain the observed incidence rate patterns. Some 
comparisons, especially by SES and enclave status, were constrained by small sample sizes 
and should therefore be interpreted with caution, and we likewise lacked sufficient sample 
size to examine trends and patterns in young adults. Furthermore, we could not cross-
classify nativity and neighborhood factors due to the lack of population data. These 
limitations are outweighed by our study’s considerable strengths, including its population-
based setting with results generalizable across California [28% of all U.S. Hispanics (65)], 
large overall sample size for evaluating anatomic and histologic subtypes as well as 
population characteristics, relatively homogeneous study population in terms of national 
origin (66), and high-quality cancer registry data, including valid data on birthplace (40), 
residential neighborhood, and Hispanic ethnicity (67, 68), that have not previously been used 
to investigate gastric cancer incidence patterns.
In summary, we found that incidence rates of most types of gastric cancer by anatomic 
subsite and histology are declining or remaining steady in foreign-born and U.S.-born 
Hispanic men and women, but that the incidence rate of diffuse gastric cancer is increasing 
in specific population segments defined by nativity and sex. Our results thus suggest that 
diffuse gastric cancer risk factors other than H. pylori may be growing increasingly 
prominent in foreign-born Hispanic men and U.S.-born Hispanic women. In addition, 
although most gastric subtypes are more common in foreign-born than U.S.-born Hispanics, 
and in those living in lower SES, higher enclave neighborhoods, cardia gastric cancer 
follows the opposite incidence patterns in Hispanic men. These patterns indicate distinct 
etiologies for anatomic and histologic subtypes of gastric cancer and also highlight the 
diversity of the growing U.S. Hispanic population (65) in terms of behavioral and 
environmental risk factors for gastric cancer. Therefore, closer examination of gastric cancer 
risk factors in distinct Hispanic subgroups may reveal new clues about why certain disease 
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subtypes are more common or increasing in some groups relative to others and offer 
guidance for potential preventive efforts.
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Figure 1. 
Time trends in gastric cancer incidence rates among Hispanic men by nativity in California, 
1988 to 2004. A, by anatomic site (cardia vs. noncardia). B, by histologic type (intestinal vs. 
diffuse).
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Figure 2. 
Time trends in gastric cancer incidence rates among Hispanic women by nativity in 
California, 1988 to 2004. A, by anatomic site (cardia vs. noncardia). B, by histologic type 
(intestinal vs. diffuse).
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